Radiofrequency ablation

The Asia Pacific radiofrequency ablation devices market is anticipated to reach US$ 1,705.06 Mn by 2027 from US$ 699.62 Mn in 2019. The market is projected to grow at a CAGR of 12.1% from 2020 to 2027

Saturday, May 23, 2020 - 1:15am

The Asia Pacific radiofrequency ablation devices market is anticipated to reach US$ 1,705.06 Mn by 2027 from US$ 699.62 Mn in 2019.

Key Points: 
  • The Asia Pacific radiofrequency ablation devices market is anticipated to reach US$ 1,705.06 Mn by 2027 from US$ 699.62 Mn in 2019.
  • The market is projected to grow at a CAGR of 12.1% from 2020 to 2027.
  • The radiofrequency ablation devices market growth is primarily attributed to the rising prevalence of chronic diseases, emerging applications of radiofrequency ablation technology, and increasing preference for minimally invasive procedures in Asia Pacific.
  • In 2019, the surgical oncology segment held the largest share of the Asia Pacific radiofrequency ablation devices market, by application, in 2019.

Thermedical’s Groundbreaking SERF Ablation System Earns FDA’s Breakthrough Device Designation

Tuesday, May 19, 2020 - 2:00pm

Thermedical , a developer of thermal-ablation medical systems to treat ventricular tachycardia (VT), today announced that it has received Breakthrough Device Designation from the U.S. Food & Drug Administration (FDA) for its Saline Enhanced Radiofrequency (SERF) Ablation system and Durablate catheter.

Key Points: 
  • Thermedical , a developer of thermal-ablation medical systems to treat ventricular tachycardia (VT), today announced that it has received Breakthrough Device Designation from the U.S. Food & Drug Administration (FDA) for its Saline Enhanced Radiofrequency (SERF) Ablation system and Durablate catheter.
  • View the full release here: https://www.businesswire.com/news/home/20200519005159/en/
    Thermedical's Durablate catheter receives Breakthrough Device Designation from the U.S. Food & Drug Administration.
  • Thermedicals SERF ablation system provides a new form of biological heat transfer that is 20 times more effective at transferring heat than conventional ablation methods.
  • The SERF VT EFS is a groundbreaking, single-arm observational study designed to evaluate the safety and effectiveness of the Durablate catheter to treat VT.

The Global Tissue Ablation Market is expected to grow from USD 13,823.13 Million in 2018 to USD 22,452.13 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 7.17%

Wednesday, April 15, 2020 - 9:00am

On the basis of Type, the Global Tissue Ablation Market is studied across Cardiology, Cosmetology, Gynecology, Oncology, Ophthalmology, and Urology.

Key Points: 
  • On the basis of Type, the Global Tissue Ablation Market is studied across Cardiology, Cosmetology, Gynecology, Oncology, Ophthalmology, and Urology.
  • On the basis of Application, the Global Tissue Ablation Market is studied across Cryoablation Devices, EBRT, Hydrothermal Ablation, Laser-Based Ablation, Microwave Ablation, Radiofrequency Ablation, and Ultrasound Ablation.
  • What are the factors that affect the growth in the Global Tissue Ablation Market over the forecast period?
  • Which are the best product areas to be invested in over the forecast period in the Global Tissue Ablation Market?

Insights on the Global Tumor Ablation Industry to 2027 - Drivers, Restraints, Opportunities & Threats - ResearchAndMarkets.com

Monday, April 6, 2020 - 5:08pm

The "Tumor Ablation - Global Market Outlook (2018-2027)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Tumor Ablation - Global Market Outlook (2018-2027)" report has been added to ResearchAndMarkets.com's offering.
  • The Global Tumor Ablation market accounted for $394.66 million in 2018 and is expected to reach $1,253.33 million by 2027 growing at a CAGR of 13.7% during the forecast period.
  • Tumor ablation is a minimally invasive image-guided technique used in the treatment of the tumors in the liver, kidney, soft tissue and bone.
  • Tumor ablation has primarily been used for the treatment of oesophagal squamous cell dysplasia, gastric antral vascular ectasia, radiation proctopathy, cholangiocarcinoma, and pancreatic neoplasia.

Global Varicose Vein Treatment Market to Clock CAGR of ~5% From 2019 to 2027, Expanding Array of New Minimally-Invasive Techniques Key to Growth: Transparency Market Research

Tuesday, February 25, 2020 - 9:03am

Constant launch of an array of new, novel minimally-invasive therapies has opened new avenues in the varicose vein treatment market.

Key Points: 
  • Constant launch of an array of new, novel minimally-invasive therapies has opened new avenues in the varicose vein treatment market.
  • The valuation of the global Varicose Vein Treatment Market stood at ~US$ 1.5 bn in 2018 and is expected to clock a CAGR of ~5% during the forecast period 20192027.
  • Advancements in endothermal ablasion or endovenous laser treatment are broadening the scope of revenue generation for players in the market.
  • They further add, "Phlebectomy is a reliable surgical treatment that is less technically challenging as compared to many other treatment options.

Tumor Ablation Market Size Worth $2.6 Billion by 2027 | CAGR: 11.2 %: Grand View Research, Inc.

Monday, February 17, 2020 - 9:05am

SAN FRANCISCO, Feb. 17, 2020 /PRNewswire/ -- The global tumor ablation market size is anticipated to reach USD 2.6 billion by 2027, according to a new report by Grand View Research, Inc.

Key Points: 
  • SAN FRANCISCO, Feb. 17, 2020 /PRNewswire/ -- The global tumor ablation market size is anticipated to reach USD 2.6 billion by 2027, according to a new report by Grand View Research, Inc.
  • Increasing incidence of cancer and high demand for effective treatment options are the major factors driving the market.
  • Integration of tumor ablation devices with efficient interventional imaging modalities such as ultrasound, MRI, and CT is anticipated to revolutionize ablation procedures performed in outpatient settings.
  • Grand View Research has segmented the global tumor ablation market on the basis of technology, treatment, application, and region:
    Tumor Ablation Technology Outlook (Volume, '000 Units; Revenue, USD Million, 2016 - 2027)

Tumor Ablation Market Size Worth $2.6 Billion by 2027 | CAGR: 11.2 %: Grand View Research, Inc.

Monday, February 17, 2020 - 9:05am

SAN FRANCISCO, Feb. 17, 2020 /PRNewswire/ -- The global tumor ablation market size is anticipated to reach USD 2.6 billion by 2027, according to a new report by Grand View Research, Inc.

Key Points: 
  • SAN FRANCISCO, Feb. 17, 2020 /PRNewswire/ -- The global tumor ablation market size is anticipated to reach USD 2.6 billion by 2027, according to a new report by Grand View Research, Inc.
  • Increasing incidence of cancer and high demand for effective treatment options are the major factors driving the market.
  • Integration of tumor ablation devices with efficient interventional imaging modalities such as ultrasound, MRI, and CT is anticipated to revolutionize ablation procedures performed in outpatient settings.
  • Grand View Research has segmented the global tumor ablation market on the basis of technology, treatment, application, and region:
    Tumor Ablation Technology Outlook (Volume, '000 Units; Revenue, USD Million, 2016 - 2027)

Study Finds SureFlex® Steerable Guiding Sheath has Greater Contact Force Stability for Radiofrequency Ablations

Thursday, January 23, 2020 - 5:00pm

TORONTO, Jan. 23, 2020 /PRNewswire/ - A study has found that use of Baylis Medical's SureFlex Steerable Guiding Sheath results in greater contact force stability for radiofrequency ablations in pulmonary vein isolations.Stable contact force has been linked to more effective ablations, a therapy in which radiofrequency energy is used to create a lesion in cardiac tissue to restore proper heart rhythm.

Key Points: 
  • TORONTO, Jan. 23, 2020 /PRNewswire/ - A study has found that use of Baylis Medical's SureFlex Steerable Guiding Sheath results in greater contact force stability for radiofrequency ablations in pulmonary vein isolations.Stable contact force has been linked to more effective ablations, a therapy in which radiofrequency energy is used to create a lesion in cardiac tissue to restore proper heart rhythm.
  • The retrospective study, entitled Choice of Steerable Sheath Impacts Contact Force Stability During Pulmonary Vein Isolation, was conducted by Drs.
  • "In evaluating the contact force of two commonly used steerable sheaths, the SureFlex Steerable Guiding Sheath and the Agilis NxT Steerable Introducer, we found a higher ratio of efficient ablation lesions suggested by a greater stability in contact force with the SureFlex sheath."
  • The SureFlex sheath was engineered to provide reliable performance through superior curve retention and consistent sheath tip contact force.

Global Laparoscopic Ablation Market 2019-2023| Evolving Opportunities with AngioDynamics and AtriCure, Inc. | Technavio

Thursday, December 12, 2019 - 6:00pm

Technavio has been monitoring the global laparoscopic ablation market and the market is poised to grow by USD 879.85 million during 2019-2023 at a CAGR of almost 10% during the forecast period.

Key Points: 
  • Technavio has been monitoring the global laparoscopic ablation market and the market is poised to grow by USD 879.85 million during 2019-2023 at a CAGR of almost 10% during the forecast period.
  • View the full release here: https://www.businesswire.com/news/home/20191212005345/en/
    Technavio has announced its latest market research report titled global laparoscopic ablation market 2019-2023 (Graphic: Business Wire)
    Read the 136-page research report with TOC on "Laparoscopic Ablation Market Analysis Report by Technique (Radiofrequency ablation, Microwave ablation, Cryoablation, and Others), by Application (Cancer, Cardiovascular procedures, Urological procedures, Gynecological procedures, and Others), by Geography (Asia, Europe, North America, and ROW), and Segment Forecasts, 2019 - 2023".
  • In addition, the emergence of next-generation laparoscopic ablation is anticipated to further boost the growth of the laparoscopic ablation market.
  • Major Five Laparoscopic Ablation Market Companies:
    AngioDynamics is headquartered in the US and operates the business under various segments such as Peripheral Vascular, Vascular Access, and Oncology/Surgery.

Global Tumor Ablation Market Growth, Trends and Forecasts (2019-2024): Radiofrequency Ablation (RFA) to Witness the Highest CAGR - ResearchAndMarkets.com

Monday, December 2, 2019 - 8:09pm

The "Tumor Ablation Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Tumor Ablation Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering.
  • Radiofrequency ablation uses high-energy radio waves for treatment, in which a thin, needle-like probe is inserted into the tumor.
  • The tumor ablation market is consolidated and consists of the few major players.
  • With technological advancements, it is believed that new companies will enter the market in the coming future with their novel techniques.